The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.

Marcel MayerPhilipp WolberJohanna PrinzLouis JansenJulia EsserSami ShabliAlexander QuaasJens Peter KlußmannShachi Jenny SharmaLisa NachtsheimChristoph Arolt

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)

The results suggest a rising SDC incidence and show that the extent of the AR and HER2 expression allows for targeted therapy in most SDC cases.

Keyphrases

poor prognosis
tertiary care
binding protein
risk factors
electronic health record
machine learning